Clinical Trial Update: Partial Tear of Supraspinatus (SSP) and Treatment With Plasma Rich in Growth Factors (PRGF) [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating plasma rich in growth factors (PRGF) for a partial tear of the supraspinatus tendon has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Tear

Drugs mentioned

• Plasma Rich in Growth Factors (PRGF)

Snippet

Sponsor: Meir Medical Center | Conditions: Partial Supraspinatus Tear | Phase 1 | Status: WITHDRAWN